MANCIA GIUSEPPE

Role
Emeritus Professor  

Publications

  • Cuspidi, C., Facchetti, R., Quarti-Trevano, F., Dell'Oro, R., Mancia, G., Grassi, G. (2024). Cardio-Ankle Vascular Index As A Marker Of Left Ventricular Hypertrophy In Treated Hypertensives: Findings From The Pamela Study. AMERICAN JOURNAL OF HYPERTENSION [10.1093/ajh/hpae022]. Detail

  • Quarti Trevano, F., Bernal, S., Facchetti, R., Cuspidi, C., Mancia, G., Grassi, G. (2024). Habitual coffee consumption and office, home, and ambulatory blood pressure: results of a 10-year prospective study. JOURNAL OF HYPERTENSION [10.1097/HJH.0000000000003709]. Detail

  • Rea, F., Corrao, G., Mancia, G. (2024). Risk of Dementia During Antihypertensive Drug Therapy in the Elderly. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 83(13 (2 April 2024)), 1194-1203 [10.1016/j.jacc.2024.01.030]. Detail

  • Mancia, G., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M., et al. (2024). Rationale of treatment recommendations in the 2023 ESH hypertension guidelines. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 121(March 2024), 4-8 [10.1016/j.ejim.2023.12.015]. Detail

  • Mancia, G., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Kjeldsen, S., et al. (2024). Rationale of the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines. HYPERTENSION, 81(5), 1021-1030 [10.1161/HYPERTENSIONAHA.124.22821]. Detail

Research projects

EU-MASCARA-Markers for Sub-Clinical Cardiovascular Risk Assessemnt
Year: 2011
Call: 2011-014 - HEALTH.2011.2.4.2-2
Grantors: UNIONE EUROPEA
Network Enabled Drug Design
Year: 2009
Call: 2009-007 - Bando Fondo per la promozione di accordi istituzionali, Bando accordi istituzionali
Integrating Genomics, clinical Research and care Hypertension
Year: 2005
Call: FP6-LIFESCIHEALTH Life sciences, genomics and biotechnology for health,LSH-2005-2.1.1-2 Hypertension and cardiovascular disease